AblaCare
AblaCare develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.
AblaCare has raised €10M across 1 funding round from 1 investor, most recently a Series A round in Jul 2019. Based in Paris, France; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€10M
€10,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2019-07
latest 2019-07
Funding by year
EUR raised per yearAblaCare — funding by year — interactive chart.
Data table
| AblaCare — funding by year | |
|---|---|
| 2019 | €10M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series A | €10M | Antoine Papiernik | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData